|
HIPK1 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 6.04372107915196E-12 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
7.40640004881499E-09 |
| Normal-vs-Stage2 |
4.42690000002077E-06 |
| Normal-vs-Stage3 |
4.12469947086436E-10 |
| Normal-vs-Stage4 |
4.31290003710671E-10 |
| Stage1-vs-Stage2 |
6.818200E-01 |
| Stage1-vs-Stage3 |
2.320100E-02 |
| Stage1-vs-Stage4 |
1.142410E-02 |
| Stage2-vs-Stage3 |
2.776800E-01 |
| Stage2-vs-Stage4 |
1.537610E-01 |
| Stage3-vs-Stage4 |
5.106200E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.33515420941421E-12 |
| Normal-vs-AfricanAmerican |
1.555740E-02 |
| Normal-vs-Asian |
3.0977999998516E-07 |
| Caucasian-vs-AfricanAmerican |
5.211900E-02 |
| Caucasian-vs-Asian |
9.313200E-01 |
| AfricanAmerican-vs-Asian |
9.406200E-02 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.04480002427465E-09 |
| Normal-vs-Female |
3.03710390170409E-11 |
| Male-vs-Female |
5.485600E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.41340000037182E-07 |
| Normal-vs-Age(41-60Yrs) |
6.03719962910532E-10 |
| Normal-vs-Age(61-80Yrs) |
1.18430043549722E-10 |
| Normal-vs-Age(81-100Yrs) |
3.376800E-03 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
3.120600E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.207630E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
4.837800E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.039820E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
6.833400E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
8.936200E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
1.097110E-03 |
| Classical-VS-Follicular |
5.839000E-01 |
| Classical-VS-Other |
4.541600E-01 |
| Classical-VS-Normal |
1.21950005649296E-10 |
| Tall-VS-Follicular |
2.984500E-03 |
| Tall-VS-Other |
5.094000E-01 |
| Tall-VS-Normal |
6.81219525233701E-11 |
| Follicular-VS-Other |
4.331800E-01 |
| Follicular-VS-Normal |
1.9117399999935E-05 |
| Other-VS-Normal |
4.504900E-03 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
6.0221000408589E-09 |
| Normal-vs-N1 |
2.93709945253795E-10 |
| N0-vs-N1 |
3.252100E-02 |
|
|
